Neurogenic pulmonary edema in subarachnoid hemorrage

Panminerva Medica

Volumn 53, Issue 3, 2011, Pages 203-210

  Piazza, O ^a   Venditto, A ^b   Tufano, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BUFALINI HOSPITAL   (Italy)

Author keywords

Aneurysm; Complications; Subarachnoid hemorrhage

Indexed keywords

ARTICLE; HUMAN; LUNG EDEMA; SUBARACHNOID HEMORRHAGE;

HUMANS; PULMONARY EDEMA; SUBARACHNOID HEMORRHAGE;

EID: 80054725326     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Parkarinen S: Incidence, aetiology and prognosis of primary subarachnoid haemorrhage: A study based on 589 cases diagnosed in a defined urban population during a defined period. Acta Neurol Scand 1967; 43(Suppl 29):1-128.
2. Haley EC, Kassell NF, Tomer JC. International cooperative study on timing of aneurysm surgery. The North American experience. Stroke 1992;23:205-14.
3. Solenski NJ, Haley EC. Medical complications of aneurismal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Study. Crit Care Med 1995;23:1007-17
4. Weisman SJ. Edema and congestion of the lung resulting from intracranial hemorrhage. Surgery 1939;6:722-9
5. Paine R, Smith JR, Howard FA. Pulmonary oedema in patients dying with disease of the central nervous system. JAMA 1952 149:643-6.
6. Richards P. Pulmonary oedema and intracranial lesions. BMJ 1963;2:83-6.
7. Weir BK, Pulmonary edema following fatal aneurysm rupture. J Neurosurgery 1978;502-7. (Pubitemid 9027036)
8. Jourdan C, Artru F. Neurogenic pulmonary edema, complication of meningeal hemorrhage: report of 4 cases Agressologie. Revue internationale de physio-biologie et de pharmacologie appliquées aux effect de l'agression 1990;31:395-403.
9. Watanabe T, Sekiguchi K. Clinical evaluation of neurogenic pulmonary edema following acute stage of subarachnoid hemorrhage. No Shinkei Geka 1992;20:417-22.
10. Di Giugno G, Rosa G. Neurogenic pulmonary edema during subarachnoid hemorrhage Minerva Anestesiol 1998;64:229-30.
11. Ochiai H, Yamakawa Y. Deformation of the ventrolateral medulla oblongata by subarachnoid hemorrhage from ruptured vertebral artery aneurysms causes neurogenic pulmonary edema. Neurol Med Chir (Tokyo) 2001;41:529-34. (Pubitemid 33111338)
12. Friedman JA, Pichelmann MA. Pulmonary complications of aneurismal subarachnoid hemorrhage. Neurosurgery 2003;52:1025-31.
13. Wartenberg KE, Schmidt JM Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006;34:617-23.
14. Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E et al. Neurogenic pulmonary edema in patients with Subarachnoid Hemorrhage. J Neurosurg Anesthesiol 2008;20:188-92.
15. Fontes RB, Aguiar PH. Acute neurogenic pulmonary edema: case reports and literature review. J Neurosurg Anesthesiol 2003; 15/2:144-50. (Pubitemid 36396527)
16. Brambrink AM, Dick WF, Neurogenic pulmonary edema. Pathogenesis, clinical picture and therapy. Anaesthesist 1997;46:953-63. (Pubitemid 27519503)
17. Carlson RW, Schaeffer RCJ, Michaels SG, Weil MH. Pulmonary edema following intracranial hemorrhage. Chest 1979;75:731-4. (Pubitemid 9221259)
18. Malik AB. Mechanisms of neurogenic pulmonary edema. Circ Res 1985;57:1-18. (Pubitemid 15238836)
19. Baumann A, Audibert G, McDonnell J, Mettes PM. Neurogenic pulmonary edema. Acta Anaesthesiol Scand 2007;51:447-55. (Pubitemid 46425736)
20. Cushing H, Concerning a definite regulatory mechanism of the vasomotor centre which controls blood pressure during cerebral compression. Bull Johns Hopkins Hosp 12: 290-292,1901
21. Inobe J, Mori T Ueyama H, Kumamoto T, Tsuda T. Neurogenic pulmonary edema induced by primary medullary hemorrhage. J Neurol Sei 2000;172:73-6. (Pubitemid 30006985)
22. Keegan MT, Lanier WL, Pulmonary edema after resection of a fourth ventricle tumor. Possible evidence for a medulla-mediated mechanism. Mayo Clin Proc 1999;74:264-8.
23. Sarnoff SJ, Sarnoff LC. Neurohemodynamics of pulmonary edema: Part II- The role of sympathetic pathways in the elevation of pulmonary and systemic vascular pressures following the intracisternal injection of fibrin. Circulation 1952;6:51-62.
24. Schwarz S, Schwab S, Keller E, Bertram M, Hacke W. Neurogenic disorders of heart and lung function in acute cerebral lesions. Nervenarzt 1997;68:956-62. (Pubitemid 28023423)
25. Deehan SC, Grant IS. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intensive Care Med 1996;22:672-6. (Pubitemid 26254277)
26. Mertes PM, el Abassi K, Jaboin Y, Burtin P, Pinelli G, Carteaux JP et al. Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation 1994;58:414-8. (Pubitemid 24271527)
27. Bowers RE, McKeen CR, Park BE, Brigham KL. Increased pulmonary vascular permeability follows intracranial hypertension in sheep. Am Rev Respir Dis 1979; 119:637-41. (Pubitemid 9155082)
28. Simon RP, Bayne LL, Tranbaugh RF, Lewis FR. Elevated pulmonary lymph flow and protein content during status epilepticus in sheep. J Appl Physiol 1982; 52:91-5. (Pubitemid 12041144)
29. McClellan MD, Dauber IM, Weil JV. Elevated intracranial pressure increases pulmonary vascular permeability to protein. J Appl Physiol 1989;67:1185-91. (Pubitemid 19245046)
30. Simon RP, Bayne LL, Naughton MP. Left atrial pressure elevation recreates the altered lymph flow of seizures. J Appl Physiol 1982;53:432-5. (Pubitemid 12049632)
31. Marón MB, Dawson CA. Pulmonary venoconstriction caused by elevated cerebrospinal fluid in the dog. J Appl Physiol 1980;49:738.
32. Johnston SC, Darragh TM, Simon RP. Postictal pulmonary edema requires pulmonary vascular pressure increases. Epilepsia 1996;37:428-32. (Pubitemid 26140596)
33. Smith WS, Matthay MA. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest 1997;111:1326-33. (Pubitemid 27200092)
34. Maron MB, Holcomb PH, Dawson CA, Rickaby DA, Clough AV, Linehan JH. Edema development and recovery in neurogenic pulmonary edema. J Appl Physiol 1994;77:1155-63 (Pubitemid 24299366)
35. Hoff JT, Nishimura M, Garcia UJ, Miranda S. Experimental neurogenic pulmonary edema: I. The role of systemic hypertension. J Neurosurg 1981;54:627-31. (Pubitemid 11156355)
36. Kowalski ML, Didier A, Kaliner MA. Neurogenic inflammation in the airways: I. Neurogenic stimulation induces plasma protein extravasation into the rat airway lumen. Am Rev Respir Dis 1989;140:101-9. (Pubitemid 19177089)
37. Minnear FL, Kite C, Hill LA, van der Zee H. Endothelial injury and pulmonary congestion characterize neurogenic pulmonary edema in rabbits. J Appl Physiol 1987;63:335-41. (Pubitemid 17107164)
38. Cameron GR, De SN. Experimental pulmonary edema of nervous origin. J Pathol Bacteriol 1949;61:375-87.
39. Theodore J, Robin ED. Pathogenesis of neurogenic pulmonary oedema. Lancet 1975;2:749-51.
40. West JB. Stress failure of pulmonary7 capillaries: role in lung and heart disease. Lancet 1992;340:762-7.
41. Bachofen H, Schurch S, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs. Am Rev Respir Dis 1993; 147:997-1004. (Pubitemid 23093829)
42. Johnston SC, Horn JK, Valente J, Simon RP. The role of hypoventilation in a sheep model of epileptic sudden death. Ann Neurol 1995;37:531-7.
43. Maron MB. Analysis of airway fluid protein concentration in neurogenic pulmonary edema. J Appl Physiol 1987;62:470-6. (Pubitemid 17066598)
44. Mayer SA, Fink ME, Homma S, Sherman D, LiMandri G, Lennihan L etal. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology 1994;44:815-20. (Pubitemid 24158792)
45. Ducker TB. Increased intracranial pressure and pulmonary edema: I. Clinical study of 11 patients. J Neurosurg 1968;28:112-7.
46. Ciongoli AK, Poser CM. Pulmonary edema secondary to subarachnoid hemorrhage. Neurology 1972;22:867-70.
47. Yabumoto M, Kuriyama T, Iwamoto M, Kinoshita T. Neurogenic pulmonary edema associated with ruptured intracranial aneurysm: case report. Neurosurgery 1986;19:300-4. (Pubitemid 16041017)
48. Scafer BW, Heizmann CW. The S100 family of EF-hand calciumbinding proteins: function and pathology. Trends Biochem Sei 1996;21:134-40.
49. Kerkhoff C, Klempt M, Sorg C.Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1998;1448:190-8.
50. Mandinova A, Atar D, Schäfer BW, Spiess M, Aebi U, Heizmann CW. Distinct subcellular localization of the calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rise in intracellular calcium. J Cell Sei 1998;111:2043-54. (Pubitemid 28391069)
51. Davey GE, Murmann P, Heizmann CW Intracellular Ca2+ and Zn 2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cell J. Biol Chem 2001;276:30819-26.
52. Brett W, Mandinova A, Remppis A, Sauder U, Rüter F, Heizmann CW et al. Translocation of S100Al calcium binding protein during heart surgery. Biochem Biophys Res Commun 2001;284:698-703. (Pubitemid 32924785)
53. Albertazzi E, Cajone F, Sherbet GV. Characterization of a splice variant of metastasis-associated h-mtsl (S100A4) gene expressed in human infiltrating carcinomas of the breast. DNA Cell Biol 1998;17:1003-8. (Pubitemid 29024794)
54. Claus W. Heizman, SlOO proteins: structure, functions and pathology. Frontiers in Bioscience 2002;7.
55. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 Protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956-60. (Pubitemid 27459003)
56. Piazza O, Cotena S, Esposito G, De Robertis E, Tufano R. S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. Minerva Chir 2005;60:477-80.
57. Piazza O, Russo E, Cotena S, Esposito G, Tufano R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 2007;99:518-21. (Pubitemid 47412494)
58. Sanchez-Pena Paola. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 2008;36:2267-73.
59. Fehrenbach H, Kasper M et al. Receptor for advanced glycation end products (RAGE) exhibits highly differential cellular and subcellular localization in rat and human lung. Cell MoI Biol 1998;44:1147-57.
60. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K et al. Receptor for advanced glycation end products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006;173:1008-15.
61. Schmidt AM, Yan SD, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-55. (Pubitemid 32946067)
62. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H et al. Novel splice variants of the receptor for advanced glycation end products expressed in human vascular endothelial cells and periocytes and their putative roles in diabetes induced vascular injury. Biochem J 2003;370:1097-109. (Pubitemid 36399105)
63. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008;63:1083-9.
64. Balaguer L, Romano J. Solitary neuroendocrine cells and neuroepithelialbodies in the lower airways of embryonic, fetal, and postnatal sheep. Anat Rec 1991;231:333-8.
65. PolakJM, Bloom SR. Regulatory peptides of the gastrointestinal and respiratory tracts. Arch Int Pharmacodyn Ther 1986; 280 (2 Suppl): 16-49. (Pubitemid 16079833)